期刊文献+

不同经皮冠状动脉介入治疗术支架植入时机对急性ST段抬高型心肌梗死疗效和预后的影响 被引量:31

Effect of different stent implantation time for percutaneous coronary intervention on efficacy and prognosis of acute ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的探讨不同经皮冠状动脉介入治疗术(PCI)支架植入时机对急性ST段抬高型心肌梗死(STEMI)疗效和预后的影响。方法根据支架植入时机,将186例行PCI的急性STEMI患者分为A组127例和B组59例,其中A组在接受经皮冠状动脉球囊扩张术(PTCA)开通罪犯血管(IRA)后,即刻植入支架;B组在接受PTCA开通IRA后,积极给予抗栓治疗,患者病情稳定后复查冠状动脉造影且靶病变狭窄>50%,延迟植入支架。比较两组患者的支架植入情况、术后效果及预后。结果B组复查冠状动脉造影未见靶血管闭塞患者,发现8例患者的靶血管狭窄≤50%,免于延迟植入支架,最终B组51例患者纳入研究。B组患者植入支架数量少于A组,植入支架长度短于A组(P<0.05)。B组术后1 h内ST段回落、心肌梗死溶栓试验(TIMI)血流分级3级、心肌染色分级(MBG)3级患者比例均高于A组,慢血流/无复流和远端栓塞患者比例均低于A组(P<0.05)。B组围手术期出现主要不良心脏事件(MACE)患者比例低于A组(P<0.05),而两组间出现靶血管再次血运重建(TVR)、严重出血、再次心肌梗死和穿刺部位并发症患者比例比较,差异均无统计学意义(P>0.05)。结论在PTCA开通急性STEMI患者IRA后,延迟植入支架较即刻植入支架明显改善心肌血流动力学,减少MACE的发生,可能使患者获益更多。 Objective To explore the effect of different stent implantation time for percutaneous coronary intervention(PCI)on efficacy and prognosis of acute ST-segment elevation myocardial infarction (STEMI).Methods A total of 186 patients with acute STEMI undergoing PCI were divided into group A (127 cases)and group B(59 cases)according to stent implantation time.Patients in group A were received immediate stent implantation after percutaneous transluminal coronary angioplasty (PTCA)openning culprit vessel(IRA),while patients in group B received PTCA openning IRA at first,then antithrombotic therapies were conducted positively.After patients turned to stable condition,coronary angiography was conducted and patients with target lesion stenosis >50%were given delayed stent implantation.Stent implantation condition ,postoperative effect and prognosis between two groups were compared.Results There were no patients with target vessels occlusion and 8 patients with target vessels stenosis ≤50% which avoided stent implantation when coronary angiography was conducted for the reexamination in group B.There were 51 patients included in group B finally.The number of implanted stents in group B was less than that in group A,and the length of implanted stentts was shorter than that in group A (P <0.05).Ratios of patients with ST segment regression within 1 h,myocardial infarction thrombolysis (TIMI)blood flow grading grade 3 and myocardial blush grading(MBG)grade 3 in group B were all higher than those in group A,while ratios of patients with slow blood flow/no reflow and distal embolization were lower than those in group A (P <0.05).Ratio of patients which suffered major adverse cardiac events (MACE)during perioperative period was lower than that in group A(P <0.05),but there were no significant differences in ratios of patients which suffered revascularization(TVR),severe hemorrhage,re-myocardial infarction and complications of puncture position between two groups(P >0.05).Conclusion After PTCA has opened IRA in patients with acute STEMI,delayed stent implantation can significantly improve myocardial hemodynamics and reduce occurrence of MACE,which can benefit patients more than immediate stent implantation.
作者 曹佳齐 丁跃有 郑宏超 Cao Jiaqi;Ding Yueyou;Zheng Hongchao(Department of Cardiology,Xuhui District Central Hospital,Shanghai 200031,China)
出处 《临床内科杂志》 CAS 2018年第12期821-824,共4页 Journal of Clinical Internal Medicine
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入治疗术 支架植入 即刻 延迟 Acute ST-segment elevation myocardial infarction Percutaneous coronary intervention Stent implantation Immediate Delayed
  • 相关文献

参考文献13

二级参考文献85

  • 1陈跃峰,杨跃进.经皮冠状动脉介入治疗术后的无再流现象[J].心血管病学进展,2005,26(1):4-8. 被引量:48
  • 2陈丹,吕安林,苑媛,李丹.急诊或延迟PTCA对急性心肌梗死QT间期离散度及心功能的长期影响[J].实用医学杂志,2005,21(23):2651-2653. 被引量:1
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4NARULA J, NAKANO M, VIRMANI R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques [Jl. J Am Coll Cardiol, 2013, 61 (10): 1041-1051.
  • 5WANG W, CHEN Y D, WANG C H, et al. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary tntervention for ST-segment elevation myocardial infaretion[Jl. Cardiology,2013, 124(3) : 153-160.
  • 6SARLI B, BAKTIR A O, SAGLAM H, et al. Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction [J3. Coron Artery Dis, 2013, 24(4) : 285-289.
  • 7WONG V W, ROSS D L, PARK K, et al. Hyperlycemia still an important predictor of adverse outcomes following AMI in the reperfusion era[J]. Diabetes Res Clin Pract, 2004, 64(2) : 85- 91.
  • 8BRENER S J, CRISTEA E, LANSKY A J, et al. Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarctionIJl. Circ Cardiovasc Interv, 2012, 5(4): 563-569.
  • 9PONTECORVO M L, SPAZIANI C, MONTONE R A, et al. Myocardial no-reflow phenomenon: recent knowledges [Jl. Recenti Prog Med, 2011, 102(2): 53-57.
  • 10MAGRO M, SPRINGELING T, VAN GEUNS R J, et al. Myocardial 'no-reflow' prevention[J]. Curr Vasc Pharmacol, 2013, 11(2) : 263-277.

共引文献2456

同被引文献253

引证文献31

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部